Rao Manasa G, Toner Lorraine E, Stone Joanne, Iwelumo Chioma A, Goldberger Cody, Roser Brittany J, Shah Ruhee, Rattner Paige, Paul Keisha S, Stoffels Guillaume, Bianco Angela
Department of Obstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York.
Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York.
Am J Perinatol. 2023 Mar;40(4):445-452. doi: 10.1055/a-1877-5973. Epub 2022 Jun 16.
This study was aimed to evaluate how the novel coronavirus disease 2019 (COVID-19) pandemic may have negatively impacted birth outcomes in patients who tested negative for the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) virus.
We conducted a retrospective cohort study using electronic health records of pregnant women admitted to a tertiary medical center in New York City, an epicenter of the pandemic. Women with a singleton gestation admitted for delivery from March 27 to May 31, 2019, and March 27 to May 31, 2020, were included. Women less than 18 years of age, those with a positive SARS-CoV-2 polymerize chain reaction (PCR) test on admission, fetal anomaly, or multiple gestation were excluded. Adverse pregnancy outcomes were compared between groups. Univariable and multivariable logistic regression analyses were used to assess outcomes. The primary outcome was preterm birth.
Women who delivered during the 2020 study interval had a significantly higher rate of hypertensive disorders of pregnancy (gestational hypertension [GHTN] or preeclampsia; odds ratio [OR] = 1.40, 95% confidence interval [CI]: 1.05-1.85; = 0.02), postpartum hemorrhage (PPH; OR = 1.77, 95% CI: 1.14-2.73; = 0.01), and preterm birth (OR = 1.49, 95% CI: 1.10-2.02; = 0.01). Gestational age at delivery was significantly lower in the 2020 cohort compared with the 2019 cohort (39.3 versus 39.4 weeks, = 0.03). After adjusting for confounding variables, multivariate analysis confirmed a persistent increase in hypertensive disorders of pregnancy (OR = 1.56, 95% CI: 1.10-2.20, = 0.01), PPH (OR = 1.74, 95% CI: 1.06-2.86, = 0.03), and preterm birth (OR = 1.72, 95% CI: 1.20-2.47, = 0.003) in patients who delivered in 2020 compared with the same period in 2019. Specifically, medically indicated preterm births increased during the pandemic (OR = 3.17, 95% CI: 1.77-5.67, < 0.0001).
Those who delivered during the COVID-19 pandemic study interval were more likely to experience hypertensive disorders of pregnancy, medically indicated preterm birth, and PPH even in the absence of SARS-CoV2 infection.
· Stressful life events can lead to adverse pregnancy outcomes.. · Even patients negative for COVID-19 experienced GHTN, preeclampsia, PPH and preterm birth during the pandemic.. · Pandemic-related stress may adversely affect perinatal outcomes..
本研究旨在评估2019年新型冠状病毒病(COVID-19)大流行可能如何对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒检测呈阴性的患者的分娩结局产生负面影响。
我们使用了纽约市一家三级医疗中心(该大流行的中心)收治的孕妇的电子健康记录进行了一项回顾性队列研究。纳入了2019年3月27日至5月31日以及2020年3月27日至5月31日期间因分娩入院的单胎妊娠妇女。排除年龄小于18岁、入院时SARS-CoV-2聚合酶链反应(PCR)检测呈阳性、胎儿异常或多胎妊娠的妇女。比较两组之间的不良妊娠结局。采用单变量和多变量逻辑回归分析来评估结局。主要结局是早产。
在2020年研究期间分娩的妇女中,妊娠高血压疾病(妊娠期高血压[GHTN]或先兆子痫;优势比[OR]=1.40,95%置信区间[CI]:1.05-1.85;P=0.02)、产后出血(PPH;OR=1.77,95%CI:1.14-2.73;P=0.01)和早产(OR=1.49,95%CI:1.10-2.02;P=0.01)的发生率显著更高。与2019年队列相比,2020年队列的分娩孕周显著更低(39.3周对39.4周,P=0.03)。在调整混杂变量后,多变量分析证实,与2019年同期相比,2020年分娩的患者中妊娠高血压疾病(OR=1.56,95%CI:1.10-2.20,P=0.01)、PPH(OR=1.74,95%CI:1.06-2.86,P=0.03)和早产(OR=1.72,95%CI:1.20-2.47,P=0.003)持续增加。具体而言,在大流行期间,医学指征性早产增加(OR=3.17,95%CI:1.77-5.67,P<0.0001)。
即使在没有SARS-CoV2感染的情况下,在COVID-19大流行研究期间分娩的妇女更有可能经历妊娠高血压疾病、医学指征性早产和PPH。
· 压力大的生活事件可导致不良妊娠结局。· 即使COVID-19检测呈阴性的患者在大流行期间也经历了GHTN、先兆子痫、PPH和早产。· 与大流行相关的压力可能对围产期结局产生不利影响。